Gene-Therapy Maker Sarepta Tanks After Patient Death
Introduction Sarepta Therapeutics, a leading biotech company specializing in gene therapy for rare diseases, recently faced a significant setback after the unfortunate death of a patient enrolled in its clinical trial. The event led to a sharp decline in Sarepta’s stock price, raising concerns among investors and medical experts about the safety of its gene … Read more
